What is the recommended first‑line therapy for scabies and the appropriate alternative treatments for infants, pregnant or lactating women, the elderly, and severe crusted scabies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Scabies Treatment

First-Line Therapy

Permethrin 5% cream is the recommended first-line treatment for scabies in all patient populations, applied to the entire body (neck down in adults, scalp-to-toes in infants and young children) for 8-14 hours, then washed off. 1, 2

  • A single application is generally curative for uncomplicated scabies. 1, 2
  • Oral ivermectin 200 μg/kg (repeated in 2 weeks) is an equally effective alternative first-line option, particularly useful when topical application is impractical or during institutional outbreaks. 1, 2
  • Ivermectin must be taken with food to ensure adequate bioavailability and epidermal penetration. 1, 2

Age-Specific Application Guidelines

Infants and Young Children (≤2 years)

  • Apply permethrin to the entire body including scalp, hairline, forehead, temples, and neck because mites commonly infest these areas in young children. 1
  • Oral ivermectin is contraindicated in children weighing <15 kg or younger than 10 years due to risk of blood-brain barrier penetration and neurotoxicity. 1

Older Children and Adults (≥10 years or ≥15 kg)

  • Apply permethrin from the neck down only, unless the patient is immunocompromised. 1
  • Oral ivermectin becomes a safe alternative in this age group. 1

Special Populations

Pregnant or Lactating Women

  • Permethrin 5% cream is the preferred treatment because ivermectin lacks sufficient safety data in pregnancy and lactation. 1, 2
  • Ivermectin is classified as "low-risk" based on limited human data but should be avoided when permethrin is available. 1

Elderly Patients

  • Standard permethrin 5% cream applied neck-down is appropriate. 2
  • Consider scalp-to-toes application if head involvement is suspected, as elderly patients may have atypical presentations. 3

Crusted (Norwegian) Scabies

Crusted scabies requires aggressive combination therapy with both topical and oral medications plus specialist consultation. 1, 2

  • Topical permethrin 5% cream applied daily for 7 days, then twice weekly until cure. 1, 2
  • Oral ivermectin 200 μg/kg on days 1,2,8,9, and 15. 1, 2
  • Single-application permethrin or single-dose ivermectin will fail due to the massive mite burden (thousands to millions of mites). 2
  • Remove thick crusts and cut nails to improve medication penetration. 4

Alternative Topical Treatments (when permethrin unavailable or fails)

  • Sulfur 6% ointment applied nightly for 3 consecutive nights (wash off before each reapplication). 1
  • Crotamiton 10% cream applied nightly for 2 nights, washed off 24 hours after the second application—shows ~60% cure rate versus ~89% for permethrin. 1
  • Benzyl benzoate 25%—~87% cure rate but causes burning sensation in ~43% of patients. 1

Contact and Environmental Management

All household members, close contacts, and sexual partners within the prior month must be treated simultaneously, even if asymptomatic. 1, 2

  • Failure to treat contacts simultaneously is the most common cause of treatment failure and reinfection. 2, 5
  • Machine-wash and dry all bedding, clothing, and towels on hot cycles, or dry-clean, or isolate from skin contact for ≥72 hours. 1, 2
  • Scabies mites cannot survive off-host for longer than 72 hours. 1
  • Fumigation of living areas is not required. 1, 2

Expected Post-Treatment Course

Pruritus and rash may persist for up to 2 weeks after successful therapy due to allergic dermatitis, not treatment failure. 1, 2

  • Do not retreat based solely on persistent itching within the first 2 weeks. 1
  • Retreatment is indicated only after 2 weeks if live mites are observed, symptoms persist beyond 2 weeks, or new lesions continue to appear. 1, 2
  • Use an alternative regimen (switch between permethrin and ivermectin) if retreatment is needed. 2

Treatments to Avoid

Lindane should never be used in children <10 years, pregnant or lactating women, or patients with extensive dermatitis due to high risk of seizures, neurotoxicity, and aplastic anemia. 1, 2

  • Applying lindane after bathing increases systemic absorption and toxicity. 2, 5
  • Lindane has the highest toxicity profile among scabicidal agents despite being inexpensive. 1

Common Pitfalls

  • Failing to treat asymptomatic sexual partners and household contacts is the most frequent cause of reinfection. 1, 5
  • Not repeating the ivermectin dose at 2 weeks allows surviving mites to repopulate. 2, 5
  • Inadequate application of topical permethrin—must apply under nails and to all body folds. 5
  • Premature retreatment within 2 weeks based on persistent itching alone leads to unnecessary medication exposure. 1
  • Using corticosteroids during active treatment can suppress inflammatory responses that help identify active infestation and may allow mites to proliferate. 2

Institutional Outbreak Management

  • Treat the entire at-risk population concurrently. 1
  • Mass oral ivermectin is recommended for ease of administration during outbreaks. 1, 6
  • Involve specialist consultation to coordinate treatment and control measures. 1

References

Guideline

Scabies Management in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Tratamiento Médico de la Escabiosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Treatment of scabies].

Atencion primaria, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.